Proton and Carbon Ion Therapy for Skull Base Chordoma
Author Information
Author(s): Rodrigues Amanda Cyntia Lima Fonseca, Tos Salem M., Shaaban Ahmed, Mantziaris Georgios, Trifiletti Daniel M.
Hypothesis
This systematic review and meta-analysis aimed to analyze the efficacy and safety of proton beam therapy (PBT) and carbon ion radiotherapy (CIRT) for skull base chordoma.
Conclusion
Both PBT and CIRT are effective treatments for skull base chordoma, with comparable long-term efficacy.
Supporting Evidence
- No significant difference was found between PBT and CIRT for 5-year local control and overall survival.
- At 3 years, PBT showed an advantage in local control (90% vs. 83% for CIRT; p=0.05).
- Both therapies demonstrated comparable progression-free survival rates.
Takeaway
Doctors studied two types of radiation therapy for a rare tumor in the skull and found that both work well, but they need to choose the best one for each patient.
Methodology
A systematic search of MEDLINE, EMBASE, CENTRAL, Web of Science, and Ovid was conducted, including studies with more than 10 patients treated with PBT or CIRT.
Potential Biases
Publication bias was suggested by asymmetrical funnel plots.
Limitations
Most studies are retrospective, leading to variability in practice protocols and patient referral patterns; long-term follow-up is required to assess treatment efficacy.
Participant Demographics
The median age of participants ranged from 13 to 58 years, with a male to female ratio of 1.21.
Statistical Information
P-Value
0.05
Confidence Interval
95% CI = 0.83 to 0.97
Statistical Significance
p=0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website